This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China(2017ZX10202102-004-002 and 2018ZX10302104-002);the Innovative Research Team in the National Natural Science Foundation of China(81721002);the National Key R&D Program of China(2017YFA0105703).
We examined the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC)infusion for immune nonresponder(INR)patients with chronic HIV-1 infection,who represent an unmet medical need even in the era ...